Literature DB >> 11205689

Serum total and lipid-bound sialic acid levels following acute myocardial infarction.

S S Gökmen1, G Kiliçli, F Ozçelik, S Gülen.   

Abstract

Although serum total sialic acid has been shown to be a cardiovascular risk factor, with elevated levels associated with increased cardiovascular mortality and also with cerebrovascular disease, the reason for the elevation in serum sialic acid content remains obscure. It has been shown that an increased output of serum proteins by the liver due to some type of acute phase reaction may be one of the possible sources of an increased serum sialic acid concentration in patients with myocardial infarction. An increase in the activity of sialidase, which cleaves the terminal sialic acid residues from oligosaccharides, glycoproteins and gangliosides, may also play an important role in the elevation of serum total sialic acid in myocardial infarction. Elevated serum total sialic acid in the blood might result either from the shedding or secreting of sialic acid from the cell membrane surface, or releasing of cellular sialic acid from the cell into the bloodstream due to cell damage after myocardial infarction. The purpose of the present study is to investigate serum total and lipid-bound sialic acid and the enzymes serum lactate dehydrogenase, creatine kinase and aspartate aminotransferase in patients with acute myocardial infarction, at 24 h post-infarction (day 1), 48 h post-infarction (day 2) and 72 h post-infarction (day 3). A possible role of cell damage in the elevation of serum total and lipid-bound sialic acid levels in these patients was also evaluated. In this study, 40 patients with myocardial infarction ranging in age from 42 to 68 years, and 26 healthy volunteers ranging in age from 45 to 71 years were included. Serum total sialic acid determination was carried out by the thiobarbituric acid method of Warren and lipid-bound sialic acfd by the method of Katopodis. Our data shows that a) there is a gradual increase in the levels of serum total sialic acid and lipid-bound sialic acid during the first three days after the acute myocardial infarction and b) the elevation in serum total sialic acid levels correlates with the elevation in lactate dehydrogenase activity only on day 1 following infarction. Therefore, either the shedding or secreting of sialic acid from the cell or cell membrane surface may be partly responsible for an increased serum sialic acid concentration especially on day 1 following myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11205689     DOI: 10.1515/CCLM.2000.197

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  6 in total

1.  Variations in the Serum Sialic Acid Profiles of Malaria Patients in Zaria, Nigeria: A Cross-Sectional Study.

Authors:  Mbateudi Danjuma Ika; Mohammed Auwal Ibrahim; Abdullahi Balarabe Sallau; Abdulmalik Abdullahi Salman; Abubakar Muhammad Sani; Murtala Bindawa Isah
Journal:  Acta Parasitol       Date:  2022-01-09       Impact factor: 1.440

2.  Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome.

Authors:  Sumitra Govindarajan; Vm Mithun Raghavan; Anand C Vasudeva Rao
Journal:  J Clin Diagn Res       Date:  2016-08-01

3.  Sialic acid in cardiovascular diseases.

Authors:  P K Nigam; V S Narain; Ajay Kumar
Journal:  Indian J Clin Biochem       Date:  2006-03

4.  Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching.

Authors:  Joon Young Song; Ji Yun Noh; Jin Soo Lee; Seong-Heon Wie; Young Keun Kim; Jacob Lee; Hye Won Jeong; Shin Woo Kim; Sun Hee Lee; Kyung-Hwa Park; Won Suk Choi; Hee Jin Cheong; Woo Joo Kim
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

5.  Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study.

Authors:  Sakhavat Abolhasani; Shahnam Valizadeh Shahbazloo; Hossein Mozafar Saadati; Neda Mahmoodi; Nafiseh Khanbabaei
Journal:  Arq Bras Cardiol       Date:  2019-08-29       Impact factor: 2.000

6.  Neuraminidase1 Inhibitor Protects Against Doxorubicin-Induced Cardiotoxicity via Suppressing Drp1-Dependent Mitophagy.

Authors:  Yating Qin; Chao Lv; Xinxin Zhang; Weibin Ruan; Xiangyu Xu; Chen Chen; Xinyun Ji; Li Lu; Xiaomei Guo
Journal:  Front Cell Dev Biol       Date:  2021-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.